Private jets owned by six of the largest U.S. drugmakers have touched down in Washington-area airports 127 times this year, ...

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...

BridgeBio Oncology Therapeutics (BBOT) targets KRAS and PI3Ka malignancies with next-generation small molecule therapeutics, ...

One catalyst happened a couple of weeks ago, when Merck's stock popped by nearly 4% on encouraging clinical data. Let's look ...

Investors are currently so focused on one type of drug that even good companies are being left on the sidelines.

The drugs are essentially laboratory-made versions of natural antibodies that help the immune system fight off RSV. The FDA ...

FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...

The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

Merck Foundation Chairman & Chief Executive Officer (CEO) and the First Lady of Zimbabwe Celebrate 7 Years of Long-Term ...

Merck (MRK) ended the recent trading session at $99.01, demonstrating a +1.42% change from the preceding day's closing price. The stock outpaced the S&P 500's daily gain of 0.21%. On the other hand, ...

Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer discussed, along with the tech battleground. Cramer highlighted ...